Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
22 Mar 2019
Change (% chg)

$-0.02 (-3.05%)
Prev Close
$0.50
Open
$0.51
Day's High
$0.51
Day's Low
$0.47
Volume
58,190
Avg. Vol
34,301
52-wk High
$1.38
52-wk Low
$0.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 0.00 -0.075
Sep 0.00 -0.088
FY 2018 Jun '18 0.00 -0.105
Mar '18 0.00 -0.131
Dec 0.00 -0.143
Sep 0.00 -0.177
FY 2017 Jun '17 0.00 -0.195
Mar '17 0.00 -0.180
Dec 0.00 -0.130
Sep 0.00 -0.230
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 8.15 19.21
P/E High - Last 5 Yrs. -- 17.90 24.21
P/E Low - Last 5 Yrs. -- 4.78 11.38
Beta 0.80 1.05 1.45
Price to Sales (TTM) -- 35.05 5.75
Price to Book (MRQ) -- 18.05 2.72
Price to Tangible Book (MRQ) 15.80 20.94 2.81
Price to Cash Flow (TTM) -- 5.60 23.43
% Owned Institutions 8.07 0.66 0.69

Dividends

  Company industry sector
Dividend Yield -- 2.48 1.98
Dividend Yield - 5 Year Avg -- 3.28 2.06
Dividend 5 Year Growth Rate -- 5.65 21.43
Payout Ratio(TTM) -- 18.68 18.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 29.09 17.08
Sales (TTM) vs TTM 1 Yr. Ago -- 20.28 10.79
Sales - 5 Yr. Growth Rate -- 26.64 13.79
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.41 113.07 36.68
EPS (TTM) vs TTM 1 Yr. Ago -61.36 -- --
EPS - 5 Yr. Growth Rate -- -4.65 10.23
Capital Spending - 5 Yr. Growth Rate -- 40.46 19.08

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 0.04
Current Ratio (MRQ) 2.27 20.35 1.65
LT Debt to Equity (MRQ) 0.00 36.32 33.82
Total Debt to Equity (MRQ) 0.00 45.39 73.35
Interest Coverage (TTM) -16.16 11.27 11.05

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.57 3.42
Gross Margin - 5 Yr. Avg. -- 45.74 3.08
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 35.10 48.01
Operating Margin (TTM) -- 161.19 35.89
Operating Margin - 5 Yr. Avg. -- 83.38 40.57
Pre-Tax Margin (TTM) -- 161.96 36.40
Pre-Tax Margin - 5 Yr. Avg. -- 84.62 41.07
Net Profit Margin (TTM) -- 160.64 29.11
Net Profit Margin - 5 Yr. Avg. -- 83.52 32.55
Effective Tax Rate (TTM) -- 4.62 20.96
Effective Tax Rate - 5 Yr. Avg. -- 3.93 20.76

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 93,726,649 58,255,148
Net Income/Employee (TTM) -2,234,290 114,375,013 21,006,288
Receivable Turnover (TTM) -- 17.55 13,366.72
Inventory Turnover (TTM) -- 5.15 1.33
Asset Turnover (TTM) 0.00 0.20 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -511.25 9.53 2.59
Return on Assets - 5 Yr. Avg. -- 4.39 2.81
Return on Investment (TTM) -992.44 13.85 0.46
Return on Investment - 5 Yr. Avg. -- 7.82 0.47
Return on Equity (TTM) -- 16.94 15.44
Return on Equity - 5 Yr. Avg. -- 7.91 19.79
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -77.23 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for DelMar Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.86%
# of Holders: 15
Total Shares Held: 2,010,803
3 Mo. Net Change: -245,407
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 2
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.